Liang Ma

机构：Sichuan University, China-Japan Friendship Hospital, West China Hospital of Sichuan University · ORCID：0000-0001-8327-7969

发表论文 219 篇 · 总被引 5787 次 · h-index 42

代表论文

• New insights in the treatment of DKD: recent advances and future prospects (2025 · BMC Nephrology · 被引 20)
• Nanoparticles Used for the Delivery of RNAi-Based Therapeutics (2025 · Pharmaceutics · 被引 17)
• A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast (PLN-74809) ameliorates organ injury and fibrogenesis in fibrotic kidney disease (2024 · European Journal of Pharmacology · 被引 15)
• Podocyte FFAR4 deficiency aggravated glomerular diseases and aging (2025 · Molecular Therapy · 被引 14)
• Peritoneal fibrosis: from pathophysiological mechanism to medicine (2024 · Frontiers in Physiology · 被引 14)
• Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia‐related chronic kidney disease (2024 · MedComm · 被引 14)